Demographic variables | Type of cancer | ||||||
Squamous cell carcinoma (%) | Retinoblastoma (%) | Kaposi sarcoma (%) | Small B cell lymphoma (%) | Other invasive carcinomas (%) | Total (%) | ||
Sex | Female | 36 (80.0) | 3 (6.7)) | 1 (2.2) | 1 (2.2) | 4 (8.9) | 45 (100) |
Male | 33 (84.6) | 3 (7.7) | 1 (2.6) | 0 (0.0) | 2 (5.1) | 39 (100) | |
Age (years) | 0–10 | 4 (40.0) | 5 (50.0) | 1 (10.0) | 0 (0.0) | 0 (0.0) | 10 (100) |
11–20 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | 1 (100) | |
21–30 | 9 (90.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 10 (100) | |
31–40 | 25 (86.2) | 0 (0.0) | 1 (3.5) | 0 (0.0) | 3 (10.3) | 29 (100) | |
41–50 | 26 (96.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (3.7) | 27 (100) | |
51–60 | 3 (75.0) | 0 (0.0) | 0 (0.0) | 1 (25.0)) | 0 (0.0) | 4 (100) | |
61–70 | 1 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | |
>70 | 1 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | |
HIV status | Negative | 9 (81.8) | 1 (9.1) | 0 (0.0) | 1 (9.1) | 0 (0.0) | 11 (100) |
Positive | 25 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 25 (100) | |
Unknown | 35 (72.9) | 5 (10.4) | 2 (4.2) | 0 (0.0) | 6 (12.5) | 48 (100) | |
Site of lesion | Eye lid/adnexa | 4 (66.7) | 0 (0.0) | 1 (16.7) | 1 (16.7) | 0 (0.0) | 6 (100) |
Conjunctiva | 51 (94.4) | 0 (0.0) | 1 (1.9) | 0 (0.0) | 2 (3.7) | 54 (100) | |
Intraocular | 10 (55.6) | 5 (27.8) | 0 (0.0) | 0 (0.0) | 3 (16.7) | 18 (00) | |
Not specified | 4 (66.7) | 1 (16.70 | 0 (0.0) | 0 (0.0) | 1 (16.7) | 6 (100) |